IBDEI1HM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23783,0)
 ;;=E11.9^^105^1189^35
 ;;^UTILITY(U,$J,358.3,23783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23783,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,23783,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,23783,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,23784,0)
 ;;=E03.9^^105^1189^26
 ;;^UTILITY(U,$J,358.3,23784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23784,1,3,0)
 ;;=3^Hypothyroidism
 ;;^UTILITY(U,$J,358.3,23784,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,23784,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,23785,0)
 ;;=N18.1^^105^1189^14
 ;;^UTILITY(U,$J,358.3,23785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23785,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,23785,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,23785,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,23786,0)
 ;;=N18.2^^105^1189^15
 ;;^UTILITY(U,$J,358.3,23786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23786,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,23786,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,23786,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,23787,0)
 ;;=N18.3^^105^1189^16
 ;;^UTILITY(U,$J,358.3,23787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23787,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,23787,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,23787,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,23788,0)
 ;;=N18.4^^105^1189^17
 ;;^UTILITY(U,$J,358.3,23788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23788,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,23788,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,23788,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,23789,0)
 ;;=N18.5^^105^1189^18
 ;;^UTILITY(U,$J,358.3,23789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23789,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,23789,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,23789,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,23790,0)
 ;;=N18.6^^105^1189^22
 ;;^UTILITY(U,$J,358.3,23790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23790,1,3,0)
 ;;=3^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,23790,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,23790,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,23791,0)
 ;;=J96.11^^105^1189^19
 ;;^UTILITY(U,$J,358.3,23791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23791,1,3,0)
 ;;=3^Chronic Respiratory Failure w/ Hypoxia
 ;;^UTILITY(U,$J,358.3,23791,1,4,0)
 ;;=4^J96.11
 ;;^UTILITY(U,$J,358.3,23791,2)
 ;;=^5008351
 ;;^UTILITY(U,$J,358.3,23792,0)
 ;;=J44.9^^105^1189^12
 ;;^UTILITY(U,$J,358.3,23792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23792,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,23792,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,23792,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,23793,0)
 ;;=E44.0^^105^1189^29
 ;;^UTILITY(U,$J,358.3,23793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23793,1,3,0)
 ;;=3^Moderate Protein-Calorie Malnutrition
 ;;^UTILITY(U,$J,358.3,23793,1,4,0)
 ;;=4^E44.0
 ;;^UTILITY(U,$J,358.3,23793,2)
 ;;=^5002787
 ;;^UTILITY(U,$J,358.3,23794,0)
 ;;=E43.^^105^1189^30
 ;;^UTILITY(U,$J,358.3,23794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23794,1,3,0)
 ;;=3^Severe Protein-Calorie Malnutrition
 ;;^UTILITY(U,$J,358.3,23794,1,4,0)
 ;;=4^E43.
 ;;^UTILITY(U,$J,358.3,23794,2)
 ;;=^5002786
 ;;^UTILITY(U,$J,358.3,23795,0)
 ;;=R64.^^105^1189^13
 ;;^UTILITY(U,$J,358.3,23795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23795,1,3,0)
 ;;=3^Cachexia
